Dark Forest Capital Management LP Agios Pharmaceuticals, Inc. Transaction History

Dark Forest Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$17.06 - $31.42 $733 - $1,351	-43 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$26.68 - $34.81 $1,147 - $1,496	43 New	43 $1,000
Q4 2021 Feb 11, 2022	SELL	$29.58 - $49.78 $11,033 - $18,567	-373 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$41.92 - $58.18 $55,921 - $77,612	-1,334 Reduced 78.15%	373 $17,000
Q2 2021 Aug 16, 2021	BUY	$52.06 - $61.27 $88,866 - $104,587	1,707 New	1,707 $94,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.89B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.